China Inc on buying spree of global healthcare assets
Surge driven by firms seeking to diversify, with slowing local growth, govt push to upgrade 'Made in China' brand
Beijing
CHINA'S healthcare companies are on an acquisition tear, attempting to buy their way into international markets like never before.
Chinese firms have announced more than US$3.9 billion in overseas acquisitions in the pharmaceutical, biotechnology and healthcare sectors this year - a pace on track to exceed last year's record total and a tenfold increase from the amount spent in all of 2012, data compiled by Bloomberg shows.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife served letter of demand, notice of claim from customers